This report is Part 4c in a series. It follows Part 1, “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” Part 2, “Report 58: Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” and Part 3, […]
Report 68: 34 Blood Vessel Inflammation, Vasculitis, Adverse Events Occurred in First 90 Days After Pfizer mRNA “Vaccine” Rollout, Including One Fatality. Half Had Onset Within Three Days of Injection. 81% of Sufferers Were Women.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote an important review of vasculitis adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through […]
Report 61: Histopathology Series Part 3 – Ute Krüger, MD, Breast Cancer Specialist, Reveals Increase in Cancers and Occurrences of “Turbo Cancers” Following Genetic Therapy “Vaccines”
This report is Part 3 in a series. It follows Part 1, “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus,” and Part 2, “Report 58: Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus.” A […]
Report 56: Histopathology Series Part 1 – Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus
Summary: Dr. Arne Burkhardt is one of eight international pathologists, physicians and scientists who were asked to perform a second autopsy, requested by friends and family of the deceased who were not satisfied with the results of the first autopsy. Thirty autopsies and three biopsies were evaluated; 15 cases […]
FDA Response To Doctor Raises New Questions
FDA Response To Doctor Raises New Questions Due to my experience in the regulated industry of biotech/pharmaceuticals for over 25 years, I’ve felt obliged to point out apparent discrepancies between regulations and practice to the FDA over the past year and a half. Below is one of those letters […]